Publication Name	World Journal of Clinical Urology
Manuscript ID	10069
Country	Japan

Received	2014-03-11 21:17
Peer-Review Started	2014-03-12 08:56
First Decision by Editorial Office Director
Return for Revision	2014-04-30 20:11
Revised	2014-05-11 20:54
Publication Fee Transferred
Second Decision by Editor	2014-06-18 15:00
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-06-18 15:18
Articles in Press	2014-06-18 15:43
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-09 13:53
Publish the Manuscript Online	2014-07-19 21:43

ISSN	2219-2816 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Observational Study
Article Title	Bone markers predict survival in castration-resistant prostate cancer patients treated with docetaxel
Manuscript Source	Invited Manuscript
All Author List	Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki, Ryo Oka, Fang-Ching Lee, Takanobu Utsumi, Masashi Yano, Shuichi Kamijima, Koji Kawamura, Takashi Imamoto and Tomohiko Ichikawa
Funding Agency and Grant Number	Funding Agency Grant Number Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan 22591761 Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan 23791792
Corresponding Author	Naoto Kamiya, Lecturer, Department of Urology, Toho University Sakura Medical Center 564-1 Shimo-shizu, Sakura-shi, Chiba 285-8741, Japan. E-mail: naoto.kamiya@med.toho-u.ac.jp
Key Words	Prostate cancer; Docetaxel chemotherapy; Carboxy-terminal pyridinoline cross-linked telopeptide parts of type-1 collagen; Alkaline phosphatase; Prognostic factor
Core Tip	This study examined the relationship between clinicopathological features and serum levels of carboxy-terminal pyridinoline cross-linked telopeptide parts of type-1 collagen (1CTP) and alkaline phosphatase (ALP) in castration-resistant prostate cancer patients treated with docetaxel. Patients were divided into two groups according to mean + SD of serum 1CTP (8.2 ng/mL) and ALP (538.2 IU/L) levels at the start of docetaxel chemotherapy. Patients with lower levels of serum 1CTP and ALP had significantly better survivals than those with higher serum levels. Serum levels of 1CTP and ALP are predictors of survival in patients with CRPC who are treated with docetaxel.
Publish Date	2014-07-19 21:43
Citation	Endo T, Kamiya N, Suzuki H, Oka R, Lee FC, Utsumi T, Yano M, Kamijima S, Kawamura K, Imamoto T, Ichikawa T. Bone markers predict survival in castration-resistant prostate cancer patients treated with docetaxel. World J Clin Urol 2014; 3(2): 139-143
URL	http://www.wjgnet.com/2219-2816/full/v3/i2/139.htm
DOI	http://dx.doi.org/10.5410/wjcu.v3.i2.139

Full Article (PDF)	WJCU-3-139.pdf
Full Article (Word)	WJCU-3-139.doc
Manuscript File	10069-Review.doc
Answering Reviewers	10069-Answering reviewers.pdf
Copyright License Agreement	10069-Copyright assignment.pdf
Peer-review Report	10069-Peer review(s).pdf
Scientific Misconduct Check	10069-CrossCheck.jpg
Scientific Editor Work List	10069-Scientific editor work list.pdf